Next Article in Journal
Pioneering Respiratory and Emergency Medicine Research During the COVID-19 Era
Previous Article in Journal
Real Index of Refraction of Normal and Cancerous Axillary Lymph Nodes in Breast Cancer Patients: Results from an Experimental Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 15
Issue 2
10.3390/jpm15020072
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of J. Pers. Med. 2022, 12(11), 1888.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888

by
Ling-Jung Yen
1,2,
Chung-Yang Yen
3,4,
Chia-Ling Li
5,
En-Chih Liao
6,7,
Kai-Chun Wang
1,8,
Meng-Chieh Shih
1,
Hung-Sen Huang
9,
Ying-Chin Chen
1,10,
Ling-Ying Lu
1,* and
Sheng-Jie Yu
9,11,*
1
Division of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
2
Department of Nursing, Meiho University, Pingtung 912009, Taiwan
3
Department of Dermatology, Taichung Veterans General Hospital, Taichung 407, Taiwan
4
School of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan
5
Children’s Medical Center, Taichung Veterans General Hospital, Taichung 407, Taiwan
6
Institute of Biomedical Sciences, MacKay Medical College, New Taipei City 25245, Taiwan
7
Department of Medicine, MacKay Medical College, New Taipei City 25245, Taiwan
8
The Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
9
Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan
10
Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
11
Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Authors to whom correspondence should be addressed.
J. Pers. Med. 2025, 15(2), 72; https://doi.org/10.3390/jpm15020072
Submission received: 31 December 2024 / Accepted: 7 January 2025 / Published: 18 February 2025
Versions Notes
The journal retracts the article “Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients” [1], cited above.
Following publication, the authors identified an issue related to the reported mouse strain used in the study and informed the Editorial Office. The original manuscript stated that C57BL/6 mice were used in the in vivo experiments, whereas the correct strain should be BALB/c mice. To address this, the authors submitted supporting documents to verify the experiments were conducted using another mouse strain.
Adhering to our complaints procedure, an investigation was conducted that confirmed that the evidence provided by the authors was not sufficient to rectify the concerns regarding the use of animal subjects in the experiments. As a result, the Editorial Board have agreed to retract this article [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 15 October 2024).
This retraction was approved by the Editor-in-Chief of the Journal of Personalized Medicine.
The authors did not agree to this retraction.

Reference

  1. Yen, L.-J.; Yen, C.-Y.; Li, C.-L.; Liao, E.-C.; Wang, K.-C.; Shih, M.-C.; Huang, H.-S.; Chen, Y.-C.; Lu, L.-Y.; Yu, S.-J. RETRACTED: Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yen, L.-J.; Yen, C.-Y.; Li, C.-L.; Liao, E.-C.; Wang, K.-C.; Shih, M.-C.; Huang, H.-S.; Chen, Y.-C.; Lu, L.-Y.; Yu, S.-J. RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888. J. Pers. Med. 2025, 15, 72. https://doi.org/10.3390/jpm15020072

AMA Style

Yen L-J, Yen C-Y, Li C-L, Liao E-C, Wang K-C, Shih M-C, Huang H-S, Chen Y-C, Lu L-Y, Yu S-J. RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888. Journal of Personalized Medicine. 2025; 15(2):72. https://doi.org/10.3390/jpm15020072

Chicago/Turabian Style

Yen, Ling-Jung, Chung-Yang Yen, Chia-Ling Li, En-Chih Liao, Kai-Chun Wang, Meng-Chieh Shih, Hung-Sen Huang, Ying-Chin Chen, Ling-Ying Lu, and Sheng-Jie Yu. 2025. "RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888" Journal of Personalized Medicine 15, no. 2: 72. https://doi.org/10.3390/jpm15020072

APA Style

Yen, L.-J., Yen, C.-Y., Li, C.-L., Liao, E.-C., Wang, K.-C., Shih, M.-C., Huang, H.-S., Chen, Y.-C., Lu, L.-Y., & Yu, S.-J. (2025). RETRACTED: Yen et al. Brevilin A Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis and Reduces Th17 Differentiation in Psoriasis Patients. J. Pers. Med. 2022, 12, 1888. Journal of Personalized Medicine, 15(2), 72. https://doi.org/10.3390/jpm15020072

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop